monARC Bionetworks

monARC Bionetworks is a digital health company focused on transforming clinical research through a patient-centric data platform. The company's technology enables patients to aggregate and share their medical records and health data, creating 'research-ready' communities that accelerate drug development for rare diseases and oncology. By providing a direct link between patients and researchers, monARC aims to reduce the time and cost of clinical trials while improving patient engagement. In January 2020, the company was acquired by Centogene to integrate its digital health capabilities into Centogene's rare disease diagnostics and data ecosystem. This acquisition allowed for the combination of genetic testing data with longitudinal clinical data to better support drug discovery and development.